Biomimetic nanomedicines for precise atherosclerosis theranostics

Biomimetic nanomedicines for precise atherosclerosis theranostics

Atherosclerosis (AS) is a leading cause of the life-threatening cardiovascular disease (CVD), creating an urgent need for efficient, biocompatible therapeutics for diagnosis and treatment. Biomimetic nanomedicines (bNMs) are moving closer to fulfilling this need, pushing back the frontier of nano-ba...

Full description

Bibliographic Details
Main Authors:	Ying Tao, Xinmiao Lan, Yang Zhang, Chenxing Fu, Lu Liu, Feng Cao, Weisheng Guo
Format:	Article
Language:	English
Published:	Elsevier 2023-11-01
Series:	Acta Pharmaceutica Sinica B
Subjects:	Nanotheranostics Atherosclerosis Biomimetic nanomedicines Drug delivery Passive targeting Active targeting
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211383522004816

Similar Items

Industrialization’s eye view on theranostic nanomedicine
by: Maharajan Sivasubramanian, et al.
Published: (2022-08-01)

Combating atherosclerosis with targeted nanomedicines: recent advances and future prospective
by: Ailar Nakhlband, et al.
Published: (2018-01-01)

Bioinspired and Biomimetic Nanomedicines for Targeted Cancer Therapy
by: Xiaoqiu Xu, et al.
Published: (2022-05-01)

Theranostic Nanomedicines for the Treatment of Cardiovascular and Related Diseases: Current Strategies and Future Perspectives
by: Natasha Manners, et al.
Published: (2022-04-01)

Moving beyond traditional therapies: the role of nanomedicines in lung cancer
by: Jingjing Zhang, et al.
Published: (2024-02-01)

Editorial: Women in nanomedicine
by: Lay-Hong Chuah, et al.
Published: (2023-01-01)

Nanomedicine-based drug delivery strategies for the treatment of atherosclerosis
by: Yongfang Lin, et al.
Published: (2024-06-01)

Overcoming vascular barriers to improve the theranostic outcomes of nanomedicines
by: Tang, Yufu, et al.
Published: (2023)

Programming assembly of biomimetic exosomes: An emerging theranostic nanomedicine platform
by: Xiao Xu, et al.
Published: (2023-10-01)

Biomimetic Nanotherapies: Red Blood Cell Based Core–Shell Structured Nanocomplexes for Atherosclerosis Management
by: Yi Wang, et al.
Published: (2019-06-01)

Neutrophil membrane biomimetic delivery system (Ptdser‐NM‐Lipo/Fer‐1) designed for targeting atherosclerosis therapy
by: Wei Li, et al.
Published: (2023-06-01)

Biomimetic nanoparticles to enhance the reverse cholesterol transport for selectively inhibiting development into foam cell in atherosclerosis
by: Li Zhu, et al.
Published: (2023-08-01)

Anti-inflammation nanomedicine shots through atherosclerotic plaques for targeted treatment and precise diagnosis
by: Liyun Zhu, et al.
Published: (2023-07-01)

Biomimetic and bioinspired nano‐platforms for cancer vaccine development
by: Chenchao Feng, et al.
Published: (2023-06-01)

Versatile biomimetic nanomedicine for treating cancer and inflammation disease
by: Zhao Zhiwen, et al.
Published: (2023-04-01)

Biomimetic Targeted Theranostic Nanoparticles for Breast Cancer Treatment
by: Suphalak Khamruang Marshall, et al.
Published: (2022-10-01)

Application of molecular dynamics simulation in self-assembled cancer nanomedicine
by: Xueli Xu, et al.
Published: (2023-05-01)

Nanomedicines for the management of diabetic nephropathy: present progress and prospects
by: Paramita Paul, et al.
Published: (2023-11-01)

Aptamer-Equipped Protamine Nanomedicine for Precision Lymphoma Therapy
by: Zihua Zeng, et al.
Published: (2020-03-01)

Cell Membrane-Coated Nanoparticles for Precision Medicine: A Comprehensive Review of Coating Techniques for Tissue-Specific Therapeutics
by: Andrés Fernández-Borbolla, et al.
Published: (2024-02-01)

Targeted PERK inhibition with biomimetic nanoclusters confers preventative and interventional benefits to elastase-induced abdominal aortic aneurysms
by: Nisakorn Yodsanit, et al.
Published: (2023-08-01)

Overcoming Vascular Barriers to Improve the Theranostic Outcomes of Nanomedicines
by: Yufu Tang, et al.
Published: (2022-05-01)

Editorial: Tumor microenvironment targeted nanomedicine: a feasible strategy for cancer imaging and theranostics
by: Yiming Xu, et al.
Published: (2023-06-01)

A novel formulation of theranostic nanomedicine for targeting drug delivery to gastrointestinal tract cancer
by: Madeeha Shahzad Lodhi, et al.
Published: (2021-10-01)

Biomimetic Nanomaterials Triggered Ferroptosis for Cancer Theranostics
by: Xinyu Zhang, et al.
Published: (2021-11-01)

Cancer Nanomedicine: Emerging Strategies and Therapeutic Potentials
by: Manman Xu, et al.
Published: (2023-06-01)

Delivery of triptolide: a combination of traditional Chinese medicine and nanomedicine
by: Rui Sun, et al.
Published: (2022-04-01)

Tango of dual nanoparticles: Interplays between exosomes and nanomedicine
by: Yabin Wang, et al.
Published: (2022-05-01)

Editorial: Advances and Challenges in Nanomedicine
by: Susan Hua, et al.
Published: (2018-11-01)

Vitamin E TPGS-Based Nanomedicine, Nanotheranostics, and Targeted Drug Delivery: Past, Present, and Future
by: Abhishesh Kumar Mehata, et al.
Published: (2023-02-01)

Supramolecular lipid nanoparticles as delivery carriers for non-invasive cancer theranostics
by: Syeda Zunaira Bukhari, et al.
Published: (2021-01-01)

Current Nanomedicine for Targeted Vascular Disease Treatment: Trends and Perspectives
by: Kyung-A Choi, et al.
Published: (2022-10-01)

The Spicy Science of Dendrimers in the Realm of Cancer Nanomedicine: A Report from the COST Action CA17140 Nano2Clinic
by: Sabrina Pricl
Published: (2023-07-01)

Nanomedicine for Diagnosis and Treatment of Atherosclerosis
by: Jingyun Cheng, et al.
Published: (2023-12-01)

Immunomodulatory Nanomedicine for the Treatment of Atherosclerosis
by: Linsey J. F. Peters, et al.
Published: (2021-07-01)

Nanodecoys: A Quintessential Candidate to Augment Theranostic Applications for a Plethora of Diseases
by: Sampreeti Chatterjee, et al.
Published: (2022-12-01)

Targeted Nanomedicine to Treat Bone Metastasis
by: Isaac M. Adjei, et al.
Published: (2018-10-01)

Synergistically Enhancing the Therapeutic Effect on Cancer, via Asymmetric Bioinspired Materials
by: Yasamin Ghahramani, et al.
Published: (2022-12-01)

Macrophage-targeted nanomedicine for the diagnosis and management of atherosclerosis
by: Ping Ping Hu, et al.
Published: (2022-09-01)

Nanoparticle-Based Approaches towards the Treatment of Atherosclerosis
by: Artur Y. Prilepskii, et al.
Published: (2020-11-01)